Epiminder Limited (ASX:EPI)
0.6400
+0.0100 (1.59%)
At close: Mar 27, 2026
Epiminder Market Cap
Epiminder has a market cap or net worth of 138.47 million as of March 27, 2026.
Market Cap
138.47M
Enterprise Value
48.97M
Revenue
648.18K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.64
Market Cap Chart
Since December 1, 2025, Epiminder's market cap has decreased from 283.42M to 138.47M, a decrease of -51.15%. That is a compound annual growth rate of -89.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 138.47M | -37.25% |
| Dec 31, 2025 | 220.68M | -22.14% |
| Dec 1, 2025 | 283.42M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lumos Diagnostics Holdings | 211.39M |
| Aroa Biosurgery | 196.92M |
| EMVision Medical Devices | 146.84M |
| SomnoMed | 142.40M |
| Cleo Diagnostics | 75.27M |
| Compumedics | 56.93M |
| HeraMED | 46.88M |
| Micro-X | 42.11M |